Metabolism-based liquid biopsy platform for early cancer detection
| Date | Round | Amount |
|---|---|---|
| Jun 2022 | Series A Stockholm cancer-diagnostics startup Elypta raised a USD21M Series A led by Bonnier Ventures. | $21M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.